FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114241569> ?p ?o ?g. }

• W2114241569 endingPage "320" @default.
• W2114241569 startingPage "310" @default.
• W2114241569 abstract "Purpose: The receptor-coupled signal transduction systems present in isolated human iridial fibroblasts (HIF) and in human iridial melanocytes (HIM) were investigated. Cell responsiveness to numerous prostaglandins (PGs), and other compounds of interest, was profiled in order to better understand their involvement in the iridial hyper-pigmentation process observed during treatment of elevated intraocular pressure with FP-receptor against PG analogs.Methods: [3H]-inositol phosphates ([3H]-IPs) generated in the cells were measured by ion-exchange chromatography followed by liquid scintillation spectroscopy. cAMP generated in the cells was quantified using an enzyme immunoassay.Results: HIF cells exhibited a robust phosphoinositide (PI) hydrolysis response to FP-class PG analogs, such as cloprostenol (potency, EC50 = 2.4 ± 0.5 nM, n = 5), fluprostenol (EC50 = 5.3 ± 0.6 nM, n = 3), PGF2α (EC50 = 54 ± 18 nM, n = 5), and latanoprost acid (EC50 = 121 ± 17 nM, n = 4). Other PGs exhibited the following potencies (EC50) for stimulating [3H]-IPs accumulation in HIF cells: PGD2 EC50 = 327 ± 195 nM, n =3; PGE2 EC50 = 550 ± 50 nM, n = 3; and two TP-receptor agonists (I-BOP, EC50 = 23 ± 8 nM, n = 3; U-46619 EC50 = 1.1 ± 0.4 µM, n = 3). Endothelin-1 (ET-1) and histamine increased [3H]-IPs production in HIF and HIM cells. HIM cells exhibited minimal PI turnover response to cloprostenol, latanoprost acid, latanoprost, PGF2α, PGE2, and histamine, but there were robust responses to ET-1 (EC50 = 4.6 nM, n = 2) and an ETB-receptor agonist (BQ-3020, EC50 = 5 nM, n = 2) that were blocked by an ETB-antagonist (BQ-788, IC50 = 21 ± 6 nM, n = 3). In the adenylyl cyclase activation assay, numerous PGs (1 and 10 µM) stimulated cAMP production in HIF cells yielding the following rank order of efficacy: PGI2 > PGE2 > misoprostil > isoproterenol = BW245C > PGD2 = PGF2α = fluprostenol. In HIM cells, PGE2 (EC50 = 1.3 ± 0.3 nM) and isoproterenol (β-agonist; EC50 = 89 ± 13 nM) potently and efficaciously stimulated cAMP production and ICI-118851 (β2-antagonist) attenuated the effects of isoproterenol. However, latanoprost acid, latanoprost, ET-1, and BW245C (DP-receptor agonist) were relatively less efficacious than isoproterenol and PGE2 in HIM cells at stimulating cAMP production.Conclusions: These studies have shown that while HIF cells express FP prostaglandin and histamine receptors coupled to phospholipase C to produce [3H]-IPs, the HIM cells lack such functionally active FP-receptors. In contrast, HIF and HIM cells express functional ET-1 receptors coupled to [3H]-IPs production and both cell-types respond to PGE2, BW245C, and isoproterenol by generating cAMP. It is concluded that human iridial fibroblasts and melanocytes respond differently to PGs and histamine, but in the same manner to ET-1, isoproterenol and BW245C. This may have relevance to the intercellular communication within the iris relative to the melanogenic processes." @default.
• W2114241569 created "2016-06-24" @default.
• W2114241569 creator A5024909155 @default.
• W2114241569 creator A5045897544 @default.
• W2114241569 date "2011-03-15" @default.
• W2114241569 modified "2023-09-30" @default.
• W2114241569 title "Intracellular Signaling in Human Iridial Fibroblasts and Iridial Melanocytes in Response to Prostaglandins, Endothelin, Isoproterenol, and Other Pharmacological Agents" @default.
• W2114241569 cites W1480852888 @default.
• W2114241569 cites W1486320121 @default.
• W2114241569 cites W1893352705 @default.
• W2114241569 cites W1975190613 @default.
• W2114241569 cites W1980315610 @default.
• W2114241569 cites W1980720641 @default.
• W2114241569 cites W1984072495 @default.
• W2114241569 cites W1985689227 @default.
• W2114241569 cites W1987558683 @default.
• W2114241569 cites W1989343033 @default.
• W2114241569 cites W1989646357 @default.
• W2114241569 cites W1991380118 @default.
• W2114241569 cites W1995230008 @default.
• W2114241569 cites W1999314095 @default.
• W2114241569 cites W2011300791 @default.
• W2114241569 cites W2014736995 @default.
• W2114241569 cites W2028098651 @default.
• W2114241569 cites W2037641913 @default.
• W2114241569 cites W2037682190 @default.
• W2114241569 cites W2040398099 @default.
• W2114241569 cites W2043532777 @default.
• W2114241569 cites W2045856913 @default.
• W2114241569 cites W2060184518 @default.
• W2114241569 cites W2061207844 @default.
• W2114241569 cites W2065486056 @default.
• W2114241569 cites W2068292865 @default.
• W2114241569 cites W2071605868 @default.
• W2114241569 cites W2078649173 @default.
• W2114241569 cites W2081382151 @default.
• W2114241569 cites W2086321796 @default.
• W2114241569 cites W2087255341 @default.
• W2114241569 cites W2091650384 @default.
• W2114241569 cites W2094473647 @default.
• W2114241569 cites W2110739474 @default.
• W2114241569 cites W2146054551 @default.
• W2114241569 cites W2149517932 @default.
• W2114241569 cites W2161014186 @default.
• W2114241569 cites W2169659526 @default.
• W2114241569 doi "https://doi.org/10.3109/02713683.2010.542869" @default.
• W2114241569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21405953" @default.
• W2114241569 hasPublicationYear "2011" @default.
• W2114241569 type Work @default.
• W2114241569 sameAs 2114241569 @default.
• W2114241569 citedByCount "6" @default.
• W2114241569 countsByYear W21142415692013 @default.
• W2114241569 countsByYear W21142415692020 @default.
• W2114241569 countsByYear W21142415692023 @default.
• W2114241569 crossrefType "journal-article" @default.
• W2114241569 hasAuthorship W2114241569A5024909155 @default.
• W2114241569 hasAuthorship W2114241569A5045897544 @default.
• W2114241569 hasConcept C1122143 @default.
• W2114241569 hasConcept C126322002 @default.
• W2114241569 hasConcept C134018914 @default.
• W2114241569 hasConcept C149601957 @default.
• W2114241569 hasConcept C170493617 @default.
• W2114241569 hasConcept C185592680 @default.
• W2114241569 hasConcept C202751555 @default.
• W2114241569 hasConcept C2778938600 @default.
• W2114241569 hasConcept C2780664492 @default.
• W2114241569 hasConcept C2909649922 @default.
• W2114241569 hasConcept C2911175447 @default.
• W2114241569 hasConcept C55493867 @default.
• W2114241569 hasConcept C71924100 @default.
• W2114241569 hasConcept C86803240 @default.
• W2114241569 hasConcept C96529984 @default.
• W2114241569 hasConceptScore W2114241569C1122143 @default.
• W2114241569 hasConceptScore W2114241569C126322002 @default.
• W2114241569 hasConceptScore W2114241569C134018914 @default.
• W2114241569 hasConceptScore W2114241569C149601957 @default.
• W2114241569 hasConceptScore W2114241569C170493617 @default.
• W2114241569 hasConceptScore W2114241569C185592680 @default.
• W2114241569 hasConceptScore W2114241569C202751555 @default.
• W2114241569 hasConceptScore W2114241569C2778938600 @default.
• W2114241569 hasConceptScore W2114241569C2780664492 @default.
• W2114241569 hasConceptScore W2114241569C2909649922 @default.
• W2114241569 hasConceptScore W2114241569C2911175447 @default.
• W2114241569 hasConceptScore W2114241569C55493867 @default.
• W2114241569 hasConceptScore W2114241569C71924100 @default.
• W2114241569 hasConceptScore W2114241569C86803240 @default.
• W2114241569 hasConceptScore W2114241569C96529984 @default.
• W2114241569 hasIssue "4" @default.
• W2114241569 hasLocation W21142415691 @default.
• W2114241569 hasLocation W21142415692 @default.
• W2114241569 hasOpenAccess W2114241569 @default.
• W2114241569 hasPrimaryLocation W21142415691 @default.
• W2114241569 hasRelatedWork W1965692775 @default.
• W2114241569 hasRelatedWork W1971985588 @default.
• W2114241569 hasRelatedWork W1983315707 @default.
• W2114241569 hasRelatedWork W1983371938 @default.
• W2114241569 hasRelatedWork W1993143965 @default.
• W2114241569 hasRelatedWork W2027913950 @default.

• next